Loading company…
Shenzhen Kaiyue Life Technology develops small-molecule inhibitors and diagnostic products for cancer research and treatment.
Founded in 2016 in Shenzhen, Kaiyue Life Technology researches and produces small-molecule inhibitors targeting RNA helicase for RAS-mutant solid tumors. It also develops RNA targets and drug candidates through its KY-T&D platform and completed pre-Series A funding in June 2023.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in